Amyloidosis explained

What amyloidosis is

Proteins are the body's building blocks, normally folded into precise shapes to do their jobs. In amyloidosis, certain proteins fold wrongly and clump together to form deposits called amyloid, which gather in tissues and organs. As these deposits build up, they can gradually interfere with how an organ works. Amyloidosis is not a single disease but a group of conditions, because different proteins can be involved and different organs can be affected. Some types are linked to problems in the bone marrow, some to long-term inflammation, and some are inherited and run in families; there is also a type that becomes more common with age. It is generally rare. Understanding that amyloid is a build-up of misfolded protein helps explain why the condition can affect so many different parts of the body.

Signs and symptoms

Because amyloid can build up in different organs, symptoms vary widely and often develop slowly, which is one reason the condition can be hard to spot. Common features depend on which organ is affected. If the heart is involved, people may become breathless, tired, or have swollen ankles. If the kidneys are affected, there can be swelling and changes in the urine, such as it looking frothy. Nerve involvement can cause numbness, tingling, or dizziness on standing. Other possible features include an enlarged tongue, easy bruising, tummy problems, weight loss and general tiredness. None of these is specific to amyloidosis on its own, and each can have many other causes. It is the overall pattern, and symptoms that do not fit a simpler explanation, that may prompt a doctor to consider amyloidosis.

How it is diagnosed

Diagnosing amyloidosis often takes several steps because it is rare and its symptoms overlap with many other conditions. Doctors usually start with a careful history, examination and blood and urine tests. To confirm amyloid, a small tissue sample (biopsy) is often taken and examined in the laboratory using special stains that reveal amyloid deposits. Further tests then help work out which type of amyloidosis it is and which organs are affected — this is important because treatment differs between types. Specialist scans and heart tests may be used to assess the organs. In the UK, there is a national specialist centre for amyloidosis, and people are often referred there or to specialist teams for detailed assessment and to plan the right treatment. Reaching a precise diagnosis and type is central to good care.

Treatment and care

Treatment depends on the type of amyloidosis and which organs are affected, so care is tailored to the individual and usually guided by specialists. A key aim is often to reduce the supply of the abnormal protein that forms amyloid — for example, by treating an underlying bone marrow problem or long-term inflammation that is driving it. At the same time, treatment supports any affected organs, such as managing heart or kidney problems, to help people feel better and protect organ function. Some inherited types have their own specific approaches. Because this is a complex, rare condition, treatment plans are individual and change over time, and are best overseen by specialist teams. Regular monitoring helps track how the condition and the organs are doing and allows treatment to be adjusted.

Living with amyloidosis

Living with amyloidosis usually means staying closely connected to a specialist team, attending regular monitoring, and managing the symptoms and organ effects as they arise. Because it can affect the heart, kidneys or other organs, day-to-day care often involves managing those specific issues, sometimes with the help of other specialists. Support from amyloidosis charities and patient organisations can be valuable for information and connection with others facing the same condition. It is important to report new or worsening symptoms — such as increasing breathlessness, marked swelling, or feeling faint — to your team promptly, and to seek urgent help if you become very unwell. The outlook varies a great deal depending on the type and how early it is found, which is why specialist assessment and ongoing care make such a difference.